CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Klotho in chronic kidney disease in Indian population

Author: 
Sandhya Sivaraman, Arun Halankar and Kavita Shalia
Subject Area: 
Health Sciences
Abstract: 

Introduction: Klotho, an anti-aging protein primarily expressed in the kidney is the suppressor of the expression of multiple aging phenotypes. Aims and Objectives: Present study aimed at analyzing the soluble alpha-Klotho levels in serum, prevalence of its KL-VS (F352V) and promoter (G-395A) polymorphisms in chronic kidney disease (CKD) patients & controls and their influence on soluble alpha-Klotho levels. Materials and Methods: CKD (N=100) and healthy Controls (N=97) were enrolled for the study. Soluble alpha-Klotho levels were analysed by ELISA at recruitment of subjects and further in CKD stage 1 & 2 (N=10), stage 3 & 4 (N= 14) and stage 5 (N=48) at 6 month. Genotyping of T42568G SNP (rs 9536314, F352V, of the KL-VS variant) and G-395A SNP (rs1207568) of the promoter polymorphism of Klotho gene was carried out by Taqman genotyping assay using Real Time PCR. The influence of the genotypes on alpha-Klotho levels was also examined. Results: As compared to the controls, there was a significant decrease in alpha -Klotho levels in CKD stage 1 & 2 (42.1%, p=0.01), stage 3 & 4 (74.2%, p=0.001) and in stage 5 (78.2%, p=0.001) in serum. However no significant change was seen in alpha-Klotho levels in patients at six months as compared to the levels at recruitment. The prevalence of heterozygous and homozygous genotypes for both these SNPs was low as compared to wild type genotype. The distribution of genotypes did not show any significant difference between CKD and Control groups and alpha-Klotho levels were not influenced by genotypes of both the polymorphisms. Conclusion: Soluble alpha-Klotho levels were found to decrease significantly at initial CKD stages. Thus, analysis of soluble alpha-Klotho levels may help in identifying CKD patients much before the severity sets in.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran